Back

Development and validation of a novel nomogram for predicting bleeding risk in patients with concomitant cancer and atrial fibrillation

19 June 2026 (15:39 - 15:48)
Organised by: Logo
Congress Presentation Part of: Translational cardio-oncology Cardio-Oncology Delegates Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Professor Jiwei Liu

First Affiliated Hospital of Dalian Medical University, Dalian (China)

4 More presentations in this session

Presentation thumbnail
Patterns of elevated coronary artery calcium and diminished myocardial perfusion reserve in premenopausal women with early breast cancer
Doctor A. Thomas (Durham, US)
Abstract Slides Video
Presentation thumbnail
HiPSC-cardiomyocyte monolayers and spheroids show different cardiotoxic responses to anti-cancer treatment
Mr K. Shead (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
CfDNA epigenetic profiling for tissue-of-origin mapping, accelerated aging, and cardiotoxicity biomarker discovery in cardio-oncology
Doctor D. Lukovic (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Ionizing radiation elicits senescence and a pro-inflammatory phenotype in human cardiac stromal cells
Miss G. Grigo (Genova, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Translational cardio-oncology
Video

The Event

Event poster

ESC Cardio-Oncology 2026

19 June 2026 15:39 CET
You may be interested in
thumbnail
Congress Presentation
New onset of atrial fibrillation in patients with cancer: risk-benefit appraisal of anticoagulants
thumbnail
Congress Session
Risk prediction and treatment options in cardio-oncology
thumbnail
Congress Presentation
Anticoagulants in cancer and atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources